Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty

NCT05302934 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-02-27

No results posted yet for this study

Summary

Prospective, multinational pilot study for evaluation of the Pheno4U data platform in Total Knee Arthroplasty (TKA) patients

Conditions

  • Degenerative Osteoarthritis
  • Rheumatoid Arthritis
  • Posttraumatic Arthropathy
  • Chronic Instability of Knee
  • Stiffness of Knee
  • Deformity Knee

Interventions

DEVICE

Pheno4U

Total Knee Arthroplasty represents a well-established, reliable and successful treatment option for end-stage bicompartmental osteoarthritis or other indications resulting in joint destruction. In general, Implantation of a total knee prosthesis improves the quality of life through pain alleviation, deformity correction, joint stabilization, and/or functional range of motion (ROM) through restoration of normal knee kinematics and functionality

Sponsors & Collaborators

  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Jörg Lützner, Prof. Dr. · Universitätsklinikum Carl Gustav Carus

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-28
Primary Completion
2027-06-30
Completion
2028-03-31

Countries

  • Germany
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05302934 on ClinicalTrials.gov